(Q47965740)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

title

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Panagiotis Zis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

Free Radical Biology and Medicine

29 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

page(s)

3-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo

29 March 2020

cites work

1 reference

12 December 2020

Incidence and course of dementia in people with Down's syndrome: findings from a population-based study.

1 reference

12 December 2020

Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease

1 reference

12 December 2020

Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity

1 reference

12 December 2020

Sequence of cognitive decline in dementia in adults with Down's syndrome.

1 reference

12 December 2020

Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome.

1 reference

12 December 2020

CSF tau and Abeta42 levels in patients with Down's syndrome

1 reference

12 December 2020

Neurological changes and emotional functioning in adults with Down Syndrome

1 reference

12 December 2020

Dementia in people with Down's syndrome.

1 reference

12 December 2020

Changes in explicit memory associated with early dementia in adults with Down's syndrome.

1 reference

12 December 2020

Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease

1 reference

12 December 2020

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

1 reference

12 December 2020

Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation.

1 reference

12 December 2020

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

1 reference

12 December 2020

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

1 reference

12 December 2020

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

1 reference

12 December 2020

Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study.

1 reference

12 December 2020

APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy

1 reference

12 December 2020

Phenotype associated with APP duplication in five families.

1 reference

12 December 2020

Dementia and mortality in persons with Down's syndrome

1 reference

12 December 2020

Increased amyloid beta protein levels in children and adolescents with Down syndrome.

1 reference

12 December 2020

Plasma amino acids and neopterin in healthy persons with Down's syndrome

1 reference

12 December 2020

Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.

1 reference

12 December 2020

Prevalence of dementia in intellectual disability using different diagnostic criteria.

1 reference

12 December 2020

Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities.

1 reference

12 December 2020

Symptoms of dementia among adults with Down's syndrome: a qualitative study.

1 reference

12 December 2020

Maladaptive behaviors related to dementia status in adults with Down syndrome.

1 reference

12 December 2020

The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID.

1 reference

12 December 2020

Oxidative stress and cognitive ability in adults with Down syndrome.

1 reference

12 December 2020

Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.

1 reference

12 December 2020

Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome

1 reference

12 December 2020

The relationship of plasma Abeta levels to dementia in aging individuals with Down syndrome

1 reference

12 December 2020

Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch)

1 reference

12 December 2020

Early Age at Menopause is Associated with Increased risk of Dementia and Mortality in Women with Down Syndrome

1 reference

12 December 2020

The neurobiology of isoprostanes and Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

12 December 2020

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging

1 reference

12 December 2020

Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome.

1 reference

12 December 2020

CSF Biomarkers for Alzheimer's Disease Diagnosis

1 reference

12 December 2020

Plasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome

1 reference

12 December 2020

Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar β-amyloid in adults with down syndrome: safety, acceptability, and feasibility.

1 reference

12 December 2020

Urine neural thread protein measurements in Alzheimer disease

1 reference

12 December 2020

Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome.

1 reference

12 December 2020

Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia

1 reference

12 December 2020

Down syndrome and dementia: seizures and cognitive decline

1 reference

12 December 2020

Posterior cortical atrophy

1 reference

12 December 2020

Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes

1 reference

12 December 2020

Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.

1 reference

12 December 2020

Oxidative stress and memory decline in adults with Down syndrome: longitudinal study.

1 reference

12 December 2020

Mild cognitive impairment in older adults

1 reference

12 December 2020

Changes in mortality and causes of death in the Swedish Down syndrome population

1 reference

12 December 2020

Neurodevelopmental and psychiatric issues in Down's syndrome: assessment and intervention.

1 reference

12 December 2020

Plasma tau levels in Alzheimer's disease

1 reference

12 December 2020

A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome.

1 reference

12 December 2020

Systemic oxidative stress in children and teenagers with Down syndrome

1 reference

12 December 2020

Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome

1 reference

12 December 2020

Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stress

1 reference

12 December 2020

Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome

1 reference

12 December 2020

Dementia diagnostic criteria in Down syndrome

1 reference

12 December 2020

Myoclonic epilepsy in Down syndrome and Alzheimer disease.

1 reference

12 December 2020

Body fluid biomarkers in Alzheimer's disease

1 reference

12 December 2020

Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer's disease patients

1 reference

12 December 2020

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

1 reference

12 December 2020

Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?

1 reference

12 December 2020

Risk of Major Cardiovascular Events in People with Down Syndrome

1 reference

12 December 2020

Conformational Effects of the A21G Flemish Mutation on the Aggregation of Amyloid β Peptide.

1 reference

12 December 2020

Cognitive Profiles on the Severe Impairment Battery Are Similar in Alzheimer Disease and Down Syndrome With Dementia.

1 reference

12 December 2020

No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease.

1 reference

12 December 2020

Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease

1 reference

12 December 2020

The amyloid hypothesis of Alzheimer's disease at 25 years

1 reference

12 December 2020

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Role of oxidative stress in Alzheimer's disease

1 reference

12 December 2020

Intracerebral haemorrhage in Down syndrome: protected or predisposed?

1 reference

12 December 2020

Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer's disease.

1 reference

12 December 2020

Plasma tau in Alzheimer disease

1 reference

12 December 2020

Personality and behavioural changes do not precede memory problems as possible signs of dementia in ageing people with Down syndrome

1 reference

12 December 2020

Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series

1 reference

12 December 2020

Best practice in caring for adults with dementia and learning disabilities.

1 reference

12 December 2020

Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity.

1 reference

12 December 2020

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome

1 reference

12 December 2020

Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer's Disease.

1 reference

12 December 2020

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome

1 reference

12 December 2020

Alzheimer's disease and Down's syndrome

1 reference

12 December 2020

Alzheimer's disease families with amyloid precursor protein mutations.

1 reference

12 December 2020

Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid beta protein (A beta) only in the form of A beta 42(43)

1 reference

12 December 2020

Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome.

1 reference

12 December 2020

Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor.

1 reference

12 December 2020

Longitudinal changes in adaptive behavior in adults with Down syndrome: interim findings from a longitudinal study.

1 reference

12 December 2020

10.1016/J.FREERADBIOMED.2017.08.024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870521%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference